Skip to main content
. 2019 Mar 21;18:196–220. doi: 10.1016/j.nano.2019.03.004

Figure 4.

Figure 4

Speculated role of nanoparticles at different stages of NiV pathogenesis, (A) Inhibition of initial attachment and membrane fusion during viral entry, (B) Inhibition of infected cell NiV-G protein interaction with Ephrin B2/B3 of a healthy cell and activated NiV-G protein's C-terminus region mediated activation of NiV-F, (C) Activation of AKT, (D) Activation of p53 phosphorylation, (E) Inhibition of viral transcription, translation and replication, (F) Modulation of viral transcription.